These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11314442)

  • 1. Screening for colorectal cancer.
    Budenholzer B
    CMAJ; 2001 Apr; 164(7):965-6; author reply 967-8. PubMed ID: 11314442
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost-effective screening strategies for colorectal cancer.
    Whynes DK; Walker AR; Hardcastle JD
    J Public Health Med; 1992 Mar; 14(1):43-9. PubMed ID: 1599742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for colorectal cancer: which test can we afford?
    Lansdorp-Vogelaar I; van Ballegooijen M; Kuipers EJ
    Z Gastroenterol; 2008 Apr; 46 Suppl 1():S38-40. PubMed ID: 18368641
    [No Abstract]   [Full Text] [Related]  

  • 4. Cost-effectiveness analysis of colorectal cancer screening strategies in Singapore: a dynamic decision analytic approach.
    Wong SS; Leong AP; Leong TY
    Stud Health Technol Inform; 2004; 107(Pt 1):104-10. PubMed ID: 15360784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for colorectal cancer.
    Brock G; Gurekas V
    CMAJ; 2001 Apr; 164(7):966; author reply 967-8. PubMed ID: 11314445
    [No Abstract]   [Full Text] [Related]  

  • 6. [Colorectal cancer screening is profitable].
    Pikkarainen P
    Duodecim; 1999; 115(17):1813-4. PubMed ID: 11941648
    [No Abstract]   [Full Text] [Related]  

  • 7. [Colorectal cancer screening: advice from the Health Council of the Netherlands].
    van Veen W; Mali WP
    Ned Tijdschr Geneeskd; 2009; 153():A1441. PubMed ID: 20003552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of mass screening for colorectal cancer: choice of fecal occult blood test and screening strategy.
    Sobhani I; Alzahouri K; Ghout I; Charles DJ; Durand-Zaleski I
    Dis Colon Rectum; 2011 Jul; 54(7):876-86. PubMed ID: 21654256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Economic evaluation of colorectal cancer screening with fecal occult blood detection].
    Maté Jiménez J
    Rev Esp Enferm Dig; 2000 Nov; 92(11):764-5. PubMed ID: 11468859
    [No Abstract]   [Full Text] [Related]  

  • 10. Methods and Economic Considerations: Group 1 Report. ESGE/UEGF Colorectal Cancer--Public Awareness Campaign. The Public/Professional Interface Workshop: Oslo, Norway, June 20 - 22, 2003. fulfillment corporate.
    Steele RJ; Gnauck R; Hrcka R; Kronborg O; Kuntz C; Moayyedi P; O'Morain C; Spicák J; Vainio H
    Endoscopy; 2004 Apr; 36(4):349-53. PubMed ID: 15057689
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy, effectiveness and cost-effectiveness of endoscopic screening methods.
    Brenner H
    Z Gastroenterol; 2008 Apr; 46 Suppl 1():S20-2. PubMed ID: 18368634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis of colorectal carcinoma. An update].
    Schneider AR; Caspary WF
    Radiologe; 2003 Feb; 43(2):105-12. PubMed ID: 12624667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for colorectal cancer.
    Allison JE
    N Engl J Med; 1993 Oct; 329(18):1352; author reply 1353-4. PubMed ID: 8413420
    [No Abstract]   [Full Text] [Related]  

  • 14. [National colorectal carcinoma screening program deserves further study; a report from the Dutch Health Council].
    van Veen WA
    Ned Tijdschr Geneeskd; 2001 Aug; 145(34):1655-7. PubMed ID: 11552370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of colorectal cancer screening with computed tomography colonography or fecal blood tests.
    Heresbach D; Chauvin P; Grolier J; Josselin JM
    Eur J Gastroenterol Hepatol; 2010 Nov; 22(11):1372-9. PubMed ID: 20802341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing risks and benefits of colorectal cancer screening in elderly patients.
    Ko CW; Sonnenberg A
    Gastroenterology; 2005 Oct; 129(4):1163-70. PubMed ID: 16230070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Health economics analysis of colorectal screening].
    Boncz I; Sebestyén A; Dózsa C; Pál M; Sándor J; Palásti J; Betlehem J; Ember I
    Magy Onkol; 2004; 48(2):111-5. PubMed ID: 15351803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of screening for colorectal cancer in France using a guaiac test versus an immunochemical test.
    Lejeune C; Dancourt V; Arveux P; Bonithon-Kopp C; Faivre J
    Int J Technol Assess Health Care; 2010 Jan; 26(1):40-7. PubMed ID: 20059779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential impact of population-based colorectal cancer screening in Canada.
    Flanagan WM; Le Petit C; Berthelot JM; White KJ; Coombs BA; Jones-McLean E
    Chronic Dis Can; 2003; 24(4):81-8. PubMed ID: 14733756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is it time to recommend screening for colorectal cancer?
    Lieberman D; Sleisenger MH
    Lancet; 1996 Nov; 348(9040):1463-4. PubMed ID: 8942770
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.